IgA nephropathy
Typical setting: Visible haematuria may occur during or shortly after mucosal infection.
Galactose-deficient IgA1-containing immune complexes deposit in mesangium and activate inflammation.
Glomerulonephritis module
Connect immune glomerular injury to haematuria, protein leakage, falling filtration, sodium retention, nephritic syndrome, and rapidly progressive kidney failure.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Different triggers converge on the condition's central pathological process.
Typical setting: Visible haematuria may occur during or shortly after mucosal infection.
Galactose-deficient IgA1-containing immune complexes deposit in mesangium and activate inflammation.
Typical setting: Nephritic syndrome follows streptococcal or other bacterial infection after a latent interval.
Microbial antigen-antibody complexes and complement activation produce diffuse glomerular inflammation.
Typical setting: Systemic autoimmune disease produces diverse renal patterns.
Nuclear antigen immune complexes deposit throughout glomeruli and activate classical complement.
Typical setting: Systemic small-vessel disease may affect kidneys, lungs, ENT tract, skin, or nerves.
ANCA primes neutrophil-mediated endothelial injury with few immune deposits.
Typical setting: Autoantibodies target the alpha-3 chain of type IV collagen.
Linear antibody binding damages glomerular and sometimes alveolar basement membranes.
Typical setting: Endocarditis, chronic infection, and viral infections can drive GN.
Persistent antigen and immune activation deposit complexes; treating infection is central.
Typical setting: Alternative-pathway dysregulation may be inherited or acquired.
Persistent complement activation injures glomeruli even without a classic immune-complex trigger.
Typical setting: Selected medicines cause ANCA vasculitis, lupus-like disease, or interstitial mimics.
Drug-triggered antibodies or immune complexes target renal microvasculature.
Mechanism chain
Follow each link and use it to predict the next clinical consequence.
Complexes, antibodies, complement, or activated neutrophils target capillary and mesangial structures.
Chemotactic fragments recruit inflammatory cells that release proteases, oxidants, and cytokines.
Keep exploring